Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Biliary Tract Diseases

Free Subscription Articles published in J Gastroenterol Retrieve available abstracts of 12 articles: HTML format

Single Articles

September 2022
1. SATAKE T, Morizane C, Rikitake R, Higashi T, et al
   The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry.
   J Gastroenterol. 2022 Sep 26. pii: 10.1007/s00535-022-01920.
   PubMed     Abstract available
   
   
   
2. ARIZUMI T, Tazuma S, Isayama H, Nakazawa T, et al
   Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis.
   J Gastroenterol. 2022 Sep 6. pii: 10.1007/s00535-022-01914.
   PubMed     Abstract available
   
   
   July 2022
3. KODAMA K, Kawaoka T, Kosaka M, Johira Y, et al
   Calcium channel blockers improve the prognosis of patients with intrahepatic cholangiocarcinoma after resection.
   J Gastroenterol. 2022 Jul 18. pii: 10.1007/s00535-022-01887.
   PubMed     Abstract available
   
   
   June 2022
4. MULLIRI A, Menahem B, Alves A, Dupont B, et al
   Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials.
   J Gastroenterol. 2022 Jun 15. pii: 10.1007/s00535-022-01886.
   PubMed     Abstract available
   
   
   April 2022
5. MORI Y, Okawara M, Fujimoto K, Oba T, et al
   Evaluation of cholecystectomy in older individuals using real-world data: a multilevel analysis based on a nationwide administrative database in Japan.
   J Gastroenterol. 2022 Apr 12. pii: 10.1007/s00535-022-01873.
   PubMed     Abstract available
   
   
   March 2022
6. SUZUKI Y, Mori T, Momose H, Matsuki R, et al
   Predictive factors for subsequent intrahepatic cholangiocarcinoma associated with hepatolithiasis: Japanese National Cohort Study for 18 years.
   J Gastroenterol. 2022 Mar 31. pii: 10.1007/s00535-022-01868.
   PubMed     Abstract available
   
   
   
7. ISAYAMA H, Tazuma S, Kokudo N, Tanaka A, et al
   Correction to: Clinical guidelines for primary sclerosing cholangitis 2017.
   J Gastroenterol. 2022 Mar 16. pii: 10.1007/s00535-022-01867.
   PubMed    
   
   
   December 2021
8. BURGHART L, Halilbasic E, Schwabl P, Simbrunner B, et al
   Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis.
   J Gastroenterol. 2021 Dec 11. pii: 10.1007/s00535-021-01839.
   PubMed     Abstract available
   
   
   November 2021
9. MATSUMOTO K, Ohfuji S, Abe M, Komori A, et al
   Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case-control study.
   J Gastroenterol. 2021 Nov 18. pii: 10.1007/s00535-021-01836.
   PubMed     Abstract available
   
   
   December 2020
10. MARUKI Y, Morizane C, Arai Y, Ikeda M, et al
    Correction to: Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study).
    J Gastroenterol. 2020 Dec 30. pii: 10.1007/s00535-020-01755.
    PubMed    
    
    
    October 2020
11. MARUKI Y, Morizane C, Arai Y, Ikeda M, et al
    Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study).
    J Gastroenterol. 2020 Oct 26. pii: 10.1007/s00535-020-01735.
    PubMed     Abstract available
    
    
    
12. YU WL, Yu G, Dong H, Chen K, et al
    Proteomics analysis identified TPI1 as a novel biomarker for predicting recurrence of intrahepatic cholangiocarcinoma.
    J Gastroenterol. 2020 Oct 21. pii: 10.1007/s00535-020-01729.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: